CD14 and paracoccidioidomycosis: In another study that analyzed mMDSCs (CD14+HLA-DR−/low cells) [11], PB- and BM-mMDSC levels from newly diagnosed or relapsed PCM patients were higher than MDSC levels from the patients at remission, and PB-mMDSC levels from patients at remission were similarly low with MDSC levels of healthy donors.